Ikeda I - Search Results

1

Acute adverse events of ultra-hypofractionated whole-breast irradiation after breast-conserving surgery for early breast cancer in Japan: an interim analysis of the multi-institutional phase II UPBEAT study.

Tokuda PJK, Mitsuyoshi T, Ono Y, Kishi T, Negoro Y, Okumura S, Ikeda I, Sakamoto T, Kokubo Y, Ashida R, Imagumbai T, Yamashita M, Tanabe H, Takebe S, Tokiwa M, Suzuki E, Yamauchi C, Yoshimura M, Mizowaki T, Kokubo M; Kyoto Radiation Oncology Study Group. Tokuda PJK, et al. Among authors: ikeda i. Breast Cancer. 2024 Jul;31(4):643-648. doi: 10.1007/s12282-024-01577-3. Epub 2024 Apr 12. Breast Cancer. 2024. PMID: 38607499 Free PMC article. Clinical Trial.

2

A pilot study of highly hypofractionated intensity-modulated radiation therapy over 3 weeks for localized prostate cancer.

Nakamura K, Ikeda I, Inokuchi H, Takayama K, Inoue T, Kamba T, Ogawa O, Hiraoka M, Mizowaki T. Nakamura K, et al. Among authors: ikeda i. J Radiat Res. 2018 Sep 1;59(5):656-663. doi: 10.1093/jrr/rry060. J Radiat Res. 2018. PMID: 30085048 Free PMC article.

3

Long-Term Outcomes of a Prospective Study on Highly Hypofractionated Intensity Modulated Radiation Therapy for Localized Prostate Cancer for 3 Weeks.

Nakamura K, Ikeda I, Inokuchi H, Aizawa R, Ogata T, Akamatsu S, Kobayashi T, Mizowaki T. Nakamura K, et al. Among authors: ikeda i. Pract Radiat Oncol. 2023 Nov-Dec;13(6):e530-e537. doi: 10.1016/j.prro.2023.06.004. Epub 2023 Jul 4. Pract Radiat Oncol. 2023. PMID: 37414247 Free article.

4

Ten-year outcomes of whole-pelvic intensity-modulated radiation therapy for prostate cancer with regional lymph node metastasis.

Nakamura K, Norihisa Y, Ikeda I, Inokuchi H, Aizawa R, Kamoto T, Kamba T, Inoue T, Yamasaki T, Akamatsu S, Kobayashi T, Ogawa O, Mizowaki T. Nakamura K, et al. Among authors: ikeda i. Cancer Med. 2023 Apr;12(7):7859-7867. doi: 10.1002/cam4.5554. Epub 2022 Dec 19. Cancer Med. 2023. PMID: 36536528 Free PMC article.

5

Correlation between urinary dose and delayed radiation cystitis after 78 Gy intensity-modulated radiotherapy for high-risk prostate cancer: A 10-year follow-up study of genitourinary toxicity in clinical practice.

Inokuchi H, Mizowaki T, Norihisa Y, Takayama K, Ikeda I, Nakamura K, Hiraoka M. Inokuchi H, et al. Among authors: ikeda i. Clin Transl Radiat Oncol. 2017 Oct 10;6:31-36. doi: 10.1016/j.ctro.2017.09.005. eCollection 2017 Oct. Clin Transl Radiat Oncol. 2017. PMID: 29594221 Free PMC article.

6

Clinical effect of multileaf collimator width on the incidence of late rectal bleeding after high-dose intensity-modulated radiotherapy for localized prostate carcinoma.

Inokuchi H, Mizowaki T, Norihisa Y, Takayama K, Ikeda I, Nakamura K, Nakamura M, Hiraoka M. Inokuchi H, et al. Among authors: ikeda i. Int J Clin Oncol. 2016 Feb;21(1):156-61. doi: 10.1007/s10147-015-0873-9. Epub 2015 Jul 12. Int J Clin Oncol. 2016. PMID: 26164689

7

Whole brain radiation therapy for primary central nervous system marginal zone lymphoma: a case report.

Sato GE, Ikeda I, Sakoda M, Matsugi K, Utsumi T, Iwasa Y, Yamauchi C. Sato GE, et al. Among authors: ikeda i. Int Cancer Conf J. 2020 Sep 8;10(1):31-34. doi: 10.1007/s13691-020-00443-1. eCollection 2021 Jan. Int Cancer Conf J. 2020. PMID: 33489698 Free PMC article.

8

Decreased acute toxicities of intensity-modulated radiation therapy for localized prostate cancer with prostate-based versus bone-based image guidance.

Nakamura K, Mizowaki T, Inokuchi H, Ikeda I, Inoue T, Kamba T, Ogawa O, Hiraoka M. Nakamura K, et al. Among authors: ikeda i. Int J Clin Oncol. 2018 Feb;23(1):158-164. doi: 10.1007/s10147-017-1174-2. Epub 2017 Jul 29. Int J Clin Oncol. 2018. PMID: 28756594 Clinical Trial.

9

Long-term outcomes of dynamic conformal arc irradiation combined with neoadjuvant hormonal therapy in Japanese patients with T1c-T2N0M0 prostate cancer: case series study.

Ikeda I, Mizowaki T, Norihisa Y, Takayama K, Kamba T, Inoue T, Nakamura E, Kamoto T, Ogawa O, Hiraoka M. Ikeda I, et al. Jpn J Clin Oncol. 2014 Feb;44(2):180-5. doi: 10.1093/jjco/hyt197. Epub 2013 Dec 29. Jpn J Clin Oncol. 2014. PMID: 24379210

10

Ten-year outcomes of intensity-modulated radiation therapy combined with neoadjuvant hormonal therapy for intermediate- and high-risk patients with T1c-T2N0M0 prostate cancer.

Mizowaki T, Norihisa Y, Takayama K, Ikeda I, Inokuchi H, Nakamura K, Kamba T, Inoue T, Kamoto T, Ogawa O, Hiraoka M. Mizowaki T, et al. Among authors: ikeda i. Int J Clin Oncol. 2016 Aug;21(4):783-790. doi: 10.1007/s10147-016-0954-4. Epub 2016 Feb 3. Int J Clin Oncol. 2016. PMID: 26843024

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

379 results

Search Page

Filters